About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Antioxidants & Redox Signaling

Editor-in-Chief: Chandan K. Sen

ISSN: 1523-0864 • 36 Issues Annually • Online ISSN: 1557-7716

Current Volume: 21

Latest Impact Factor* is 7.667

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

Featured Press Releases and Editorial Content

  • Dipak K. Das (1946-2013)
  • Rebound Peer Review: A Viable Recourse for Aggrieved Authors?...Read Now
  • Hydrogen Sulfide Treatment Promotes Glucose Uptake by Increasing Insulin Receptor Sensitivity and Ameliorates Kidney Lesions in Type 2 Diabetes...Read Now
  • Testing the Rebound Peer Review Concept...Read Now

Overview

Antioxidants & Redox Signaling (ARS) is the leading journal dedicated to the understanding of redox principles governing health and disease. This Journal provides and explores key aspects of the important and expanding world of redox-based therapeutics—genetic, pharmacological, and nutritional. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.

ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.

ARS coverage includes:

  • ROS/RNS as messengers
  • Gaseous signal transducers
  • Hypoxia and tissue oxygenation
  • microRNA
  • Prokaryotic systems
  • Lessons from plant biology

ARS is under the editorial leadership of Editor-in-Chief Chandan K. Sen, PhD, The Ohio State University Wexner Medical Center, and other leading investigators. View the entire editorial board.

Audience: Cell biologists, molecular biologists, biochemists, medical researchers, and nutritionists, among others.

ARS provides "Instant Online" publication 72 hours after acceptance.
Average time to first decision: 18 days
Average time to triage decision: 48 hours

Indexed/Abstracted in:

MEDLINE; PubMed; PubMed Central; Current Contents®/Life Sciences; Science Citation Index Expanded; Science Citation Index®; Biochemistry & Biophysics Citation Index®; Biological Abstracts; BIOSIS Previews; Journal Citation Reports/Science Edition; EMBASE/Excerpta Medica; EMBiology; Scopus; Chemical Abstracts; ProQuest
 

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    DNA and Cell Biology

    DNA and Cell Biology

    Combining mechanistic and clinical studies from multiple systems in a single resource, the Journal delivers authoritative, peer-reviewed reporting on the latest research in the field of molecular biology.

    Rejuvenation Research

    Rejuvenation Research

    Key explorations and cutting-edge advancements on the molecular and cellular mechanisms that may ultimately contribute to slowing or reversing the aging process.

    Journal of Medicinal Food

    Journal of Medicinal Food

    Delivers original research on the chemistry and biochemistry of the bioactive constituents of food, and substantiates their efficacy, safety, and potential uses for the prevention and treatment of disease.

Browse All Publications »